Patients and caregivers’ core aspirations to maximize the attractiveness of ASPIRE - a phase 2b trial to investigate the disease modifying potential of buloxibutid in IPF
Year: 2024
Type: conference-abstract
Authors: Asa Magnusson, Cecilia Ganslandt, Sofie Gro Søndergaard, Louisa Channouf Jacobsen, Gry Willum Hagelund, Anne Katrine Cohrt
Institution: Vicore Pharma (Sweden)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404100326